UPLIZNA 100 MG CONCENTRADO PARA SOLUCION PARA PERFUSION
UPLIZNA 100 MG CONCENTRADO PARA SOLUCION PARA PERFUSION
Commercialized
Register Number
1211602001
Prescription Type
Uso Hospitalario
Authorization Date
Jul 22, 2022
Dosage Form
CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Route: VÍA INTRAVENOSA
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number1211602001
EMA Approved
Yes
Drug Classification
✗
Generic
No
✗
Orphan
No
✗
Biosimilar
No
✓
Commercialized
Yes
CIMA AEMPS Classification
INGREDIENTS (1)
INEBILIZUMABActive
Quantity: 10 mg/ml
Name: INEBILIZUMAB
ATC CLASSIFICATION (3)
L04A
L04AG
L04AG10